NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

Envista Holdings Corporation (NVST) Stock Analysis

Envista Holdings Corporation (NVST) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

NVST

$23.19

+$0.22 (+0.96%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NVST with… →

NVST Key Statistics

As of Oct 21, 2026
Trading
Open
$22.94
Previous Close
$22.97
Day's Range
22.83–23.19
52-Week Range
18.77–30.42
Volume
5.30M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.89
Valuation
Market Cap
$3.72B
P/E Ratio
39.31
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
13.96
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.30
EPS (ttm)Profit attributable to each share over the last twelve months.
0.59
Financials (FY)
Revenue (FY)
$2.72B+8.32%
Net Income (FY)
$47.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
3.33%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
160.62M
1-Year Return
+15.49%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
2.83M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NVST closed at $23.19, +15.49% over 1 year.

Envista Holdings Corporation (NVST) has a market capitalization of $3.72B.

In fiscal 2025, NVST reported revenue of $2.72B.

NVST Stock Return by Calendar Year

Envista Holdings Corporation (NVST) return since Sep 2019: what $10,000 became

1 year
$10,000 $11,549
+15.49%
5 years
$10,000 $5,985
−40.15%
Since Sep 2019
$10,000 $8,297
−17.03%

If you had invested $10,000 in Envista Holdings Corporation (NVST) at the close on September 18, 2019, the earliest close on record here, it would have been worth $8,297 at the close on October 21, 2026: −17.03% in total, −2.60% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+6.82%
2025+12.55%
2024−19.83%
2023−28.54%
2022−25.28%
2021+33.59%
2020+13.80%
2019 (partial year)+6.05%

As of October 21, 2026.

NVST Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.72B$47.00M1.7%
2024$2.51B−$1.12B−44.6%
2023$2.57B−$100.20M−3.9%
2022$2.57B$243.10M9.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.72B$1.49B$235.80M$47.00M1.7%
2024$2.51B$1.37B$137.20M−$1.12B−44.6%
2023$2.57B$1.44B$314.90M−$100.20M−3.9%
2022$2.57B$1.47B$343.20M$243.10M9.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NVST Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricNVSTMedical Instruments & Supplies medianvs median
P/E39.3131.1926% above
P/S ratio1.302.6050% below
Profit margin3.33%1.62%1.7 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Envista Holdings Corporation (NVST) at $3.72B. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 12,000 employees.

Over the past 52 weeks the price has ranged from $18.77 to $30.42. The most recent close on file for NVST is $23.19, dated October 21, 2026. That is +$0.22 (+0.96%) against the previous close. The latest close sits 23.55% above that 52-week low.

Financial Health

In fiscal 2025, Envista Holdings Corporation reported revenue of $2.72B. Against the prior fiscal year total of $2.51B, that is a change of +8.32%. Net income for the same year was $47.00M. Profit margin runs at 3.33%. That is 1.7 percentage points above the Medical Instruments & Supplies median of 1.62%. Earnings per share on a trailing basis come to 0.59.

Across the 4 fiscal years on file, revenue moves from $2.57B in 2022 to $2.72B in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 39.31. That is 26.03% above the Medical Instruments & Supplies median of 31.19. On forward earnings the ratio is 13.96. Measured against sales, the shares trade at 1.3 times revenue. On price-to-sales that is 49.8% below the Medical Instruments & Supplies median of 2.6. The medians here are taken across 50 Medical Instruments & Supplies companies that report the metric.

The trailing one-year total return is +15.49%. Measured over 5 years, that is −9.76% a year compounded. The reported beta is 0.89. Daily returns over the trailing 7 years annualize to a volatility of 39.52%.

Growth & Income

No dividend is on file for NVST.

Across the complete calendar years on file, 2021 returned +33.59% and 2023 returned −28.54%. Of the 6 complete calendar years on file, 3 finished higher. So far in 2026 the total return is +6.82%.

Peer Comparison

Envista Holdings Corporation (NVST) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Envista Holdings Corporation NVST $3.72B 39.3
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. Envista Holdings Corporation trades at a P/E of 39.3.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 RMD

ResMed Inc.

$34.63B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Visit website →